FDA approves shock wave device for treatment of diabetic foot ulcers

January 1, 2018January 1, 2018 Wound Care Advisor

On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.

Related posts

• 

  Silk wound dressing helps eliminate scar tissue formation

  Researchers from Huazhong University of Science and Technology, China...

• 

  Predicting diabetic foot ulcer healing improves with thermal imaging

  A first of its kind study between RMIT University,...

• 

  Biotech startup announces patent for regenerative tissue therapy

  BioLab Sciences, an innovator in regenerative medicine technologies, has...

• 

  Electrically charged bandages help to heal burn wounds, combat antibiotic resistance

  Ohio State University Wexner Medical Center researchers have created...

• 

  Diabetic foot ulcers heal faster with probiotic supplementation

  Findings from a randomized controlled trial revealed that patients with...

• 

  Topical gel containing blood pressure drugs shown effective in healing chronic wounds

  An international research team led by Johns Hopkins University...